MoneyWorks4Me

Venus Remedies - Quaterly Results

30 Jan 2026 Evaluate
The quarter ended December 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1799.50 millions.Net profit for the quarter ended December 2025 increases to Rs. 249.20  millions from Rs. 240.80 millions.Operating profit surged to 391.30 millions from the corresponding previous quarter of 246.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1799.50 1722.00 4.50 5044.50 4477.30 12.67 6394.60 5752.10 11.17
Other Income 24.10 20.80 15.87 120.90 117.00 3.33 207.80 113.20 83.57
PBIDT 391.30 246.50 58.74 913.00 614.70 48.53 907.70 722.00 25.72
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 391.30 345.60 13.22 913.00 713.80 27.91 1006.80 722.00 39.45
Depreciation 63.20 52.00 21.54 181.90 171.30 6.19 216.20 255.50 -15.38
PBT 328.10 293.60 11.75 731.10 542.50 34.76 790.60 466.50 69.47
TAX 78.90 52.80 49.43 172.60 164.60 4.86 265.10 161.50 64.15
Deferred Tax -3.60 -21.00 -82.86 -11.40 28.20 -140.43 46.50 39.30 18.32
PAT 249.20 240.80 3.49 558.50 377.90 47.79 525.50 305.00 72.30
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 21.74 14.31 51.91 18.10 13.73 31.83 14.19 12.55 13.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..